Home ➤ Life Science ➤ Therapeutics ➤ Non-alcoholic Steatohepatitis Treatment Market
Non-alcoholic Steatohepatitis Treatment Market
Published date: June 2025 • Formats:
Request Sample Schedule a Call

Non-alcoholic Steatohepatitis Treatment Market By Drug (Vitamin E & Pioglitazone, Semaglutide, Obeticholic Acid (OCA), Lanifibranor, and Others), By Disease Stage (NASH Stage F4, NASH Stage F3, NASH Stage F2, NASH Stage F1, and NASH Stage F0), By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: June 2025
  • Report ID: 151363
  • Number of Pages: 254
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Non-alcoholic Steatohepatitis Treatment Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Non-alcoholic Steatohepatitis Treatment Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Non-alcoholic Steatohepatitis Treatment Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 3.3. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
        • 3.3.1. Vitamin E & Pioglitazone
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Semaglutide
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Obeticholic Acid (OCA)
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Lanifibranor
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
        • 3.3.5. Others
          • 3.3.5.1. Insights
          • 3.3.5.2. Key Takeaways
      • 3.4. Global Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Stage, 2020-2034
      • 3.5. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
        • 3.5.1. NASH Stage F1
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. NASH Stage F2
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. NASH Stage F3
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. NASH Stage F4
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. NASH Stage F0
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
      • 3.6. Global Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 3.7. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
        • 3.7.1. Hospital Pharmacies
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Retail & Specialty Pharmacies
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
    • 4. Global Non-alcoholic Steatohepatitis Treatment Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Region
    • 5. North America Non-alcoholic Steatohepatitis Treatment Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 5.3. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • 5.4. North America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Stage, 2020-2034
      • 5.5. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • 5.6. North America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 5.7. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • 5.8. North America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Non-alcoholic Steatohepatitis Treatment Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 6.3. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • 6.4. Europe Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Stage, 2020-2034
      • 6.5. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • 6.6. Europe Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 6.7. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • 6.8. Europe Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 7.3. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • 7.4. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Stage, 2020-2034
      • 7.5. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • 7.6. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 7.7. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • 7.8. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Non-alcoholic Steatohepatitis Treatment Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 8.3. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • 8.4. Latin America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Stage, 2020-2034
      • 8.5. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • 8.6. Latin America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 8.7. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • 8.8. Latin America Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 9.3. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • 9.4. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Stage, 2020-2034
      • 9.5. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • 9.6. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 9.7. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • 9.8. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. The Bristol-Myers Squibb Company
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Shilpa Medicare
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Novo Nordisk A/S
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. NGM Biopharmaceuticals, Inc
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Madrigal Pharmaceuticals Inc
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Inventiva
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Galmed Pharmaceuticals Ltd
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. AbbVie Inc
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 2. Global Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 3. Global Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 4. Global Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Region, 2020-2034
      • Table 5. North America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 6. North America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 7. North America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 8. North America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 9. The US Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 10. The US Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 11. The US Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 12. Canada Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 13. Canada Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 14. Canada Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 15. Europe Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 16. Europe Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 17. Europe Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 18. Europe Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 19. Germany Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 20. Germany Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 21. Germany Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 22. The UK Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 23. The UK Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 24. The UK Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 25. France Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 26. France Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 27. France Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 28. Spain Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 29. Spain Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 30. Spain Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 31. Italy Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 32. Italy Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 33. Italy Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 34. Russia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 35. Russia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 36. Russia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 37. Netherland Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 38. Netherland Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 39. Netherland Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 40. Rest of Europe Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 41. Rest of Europe Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 42. Rest of Europe Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 43. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 44. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 45. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 46. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 47. China Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 48. China Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 49. China Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 50. India Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 51. India Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 52. India Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 53. Japan Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 54. Japan Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 55. Japan Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 56. South Korea Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 57. South Korea Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 58. South Korea Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 59. Australia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 60. Australia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 61. Australia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 62. New Zealand Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 63. New Zealand Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 64. New Zealand Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 65. Singapore Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 66. Singapore Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 67. Singapore Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 68. Thailand Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 69. Thailand Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 70. Thailand Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 71. Vietnam Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 72. Vietnam Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 73. Vietnam Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 74. Rest of Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 75. Rest of Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 76. Rest of Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 77. Latin America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 78. Latin America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 79. Latin America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 80. Latin America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 81. Brazil Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 82. Brazil Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 83. Brazil Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 84. Mexico Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 85. Mexico Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 86. Mexico Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 87. Rest of Latin America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 88. Rest of Latin America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 89. Rest of Latin America Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 90. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 91. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 92. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 93. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 94. South Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 95. South Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 96. South Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 97. Saudi Arabia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 98. Saudi Arabia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 99. Saudi Arabia Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 100. UAE Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 101. UAE Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 102. UAE Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 103. Rest of Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Drug, 2020-2034
      • Table 104. Rest of Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Disease Stage, 2020-2034
      • Table 105. Rest of Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
    • List of Figures
      • Figure 1. Global Non-alcoholic Steatohepatitis Treatment Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Non-alcoholic Steatohepatitis Treatment Market
      • Figure 5. Global Non-alcoholic Steatohepatitis Treatment Market Analysis, By Drug, 2020, 2024 and 2034
      • Figure 6. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • Figure 7. Global Non-alcoholic Steatohepatitis Treatment Market Analysis, By Disease Stage, 2020, 2024 and 2034
      • Figure 8. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • Figure 9. Global Non-alcoholic Steatohepatitis Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 10. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 11. Global Non-alcoholic Steatohepatitis Treatment Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Region
      • Figure 13. North America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Drug, 2020, 2024 and 2034
      • Figure 14. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • Figure 15. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Vitamin E & Pioglitazone, 2020-2034
      • Figure 16. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Semaglutide, 2020-2034
      • Figure 17. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Obeticholic Acid (OCA), 2020-2034
      • Figure 18. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Lanifibranor, 2020-2034
      • Figure 19. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 20. North America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Disease Stage, 2020, 2024 and 2034
      • Figure 21. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • Figure 22. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F1, 2020-2034
      • Figure 23. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F2, 2020-2034
      • Figure 24. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F3, 2020-2034
      • Figure 25. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F4, 2020-2034
      • Figure 26. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F0, 2020-2034
      • Figure 27. North America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 28. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 29. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 30. North America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Retail & Specialty Pharmacies, 2020-2034
      • Figure 31. North America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 32. North America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
      • Figure 33. Europe Non-alcoholic Steatohepatitis Treatment Market Analysis, By Drug, 2020, 2024 and 2034
      • Figure 34. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • Figure 35. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Vitamin E & Pioglitazone, 2020-2034
      • Figure 36. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Semaglutide, 2020-2034
      • Figure 37. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Obeticholic Acid (OCA), 2020-2034
      • Figure 38. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Lanifibranor, 2020-2034
      • Figure 39. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 40. Europe Non-alcoholic Steatohepatitis Treatment Market Analysis, By Disease Stage, 2020, 2024 and 2034
      • Figure 41. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • Figure 42. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F1, 2020-2034
      • Figure 43. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F2, 2020-2034
      • Figure 44. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F3, 2020-2034
      • Figure 45. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F4, 2020-2034
      • Figure 46. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F0, 2020-2034
      • Figure 47. Europe Non-alcoholic Steatohepatitis Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 48. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 49. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 50. Europe Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Retail & Specialty Pharmacies, 2020-2034
      • Figure 51. Europe Non-alcoholic Steatohepatitis Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 52. Europe Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
      • Figure 53. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Analysis, By Drug, 2020, 2024 and 2034
      • Figure 54. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • Figure 55. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Vitamin E & Pioglitazone, 2020-2034
      • Figure 56. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Semaglutide, 2020-2034
      • Figure 57. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Obeticholic Acid (OCA), 2020-2034
      • Figure 58. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Lanifibranor, 2020-2034
      • Figure 59. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 60. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Analysis, By Disease Stage, 2020, 2024 and 2034
      • Figure 61. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • Figure 62. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F1, 2020-2034
      • Figure 63. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F2, 2020-2034
      • Figure 64. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F3, 2020-2034
      • Figure 65. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F4, 2020-2034
      • Figure 66. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F0, 2020-2034
      • Figure 67. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 68. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 69. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 70. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Retail & Specialty Pharmacies, 2020-2034
      • Figure 71. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 72. Asia Pacific Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
      • Figure 73. Latin America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Drug, 2020, 2024 and 2034
      • Figure 74. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • Figure 75. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Vitamin E & Pioglitazone, 2020-2034
      • Figure 76. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Semaglutide, 2020-2034
      • Figure 77. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Obeticholic Acid (OCA), 2020-2034
      • Figure 78. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Lanifibranor, 2020-2034
      • Figure 79. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 80. Latin America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Disease Stage, 2020, 2024 and 2034
      • Figure 81. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • Figure 82. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F1, 2020-2034
      • Figure 83. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F2, 2020-2034
      • Figure 84. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F3, 2020-2034
      • Figure 85. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F4, 2020-2034
      • Figure 86. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F0, 2020-2034
      • Figure 87. Latin America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 88. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 89. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 90. Latin America Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Retail & Specialty Pharmacies, 2020-2034
      • Figure 91. Latin America Non-alcoholic Steatohepatitis Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 92. Latin America Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
      • Figure 93. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Analysis, By Drug, 2020, 2024 and 2034
      • Figure 94. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Drug
      • Figure 95. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Vitamin E & Pioglitazone, 2020-2034
      • Figure 96. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Semaglutide, 2020-2034
      • Figure 97. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Obeticholic Acid (OCA), 2020-2034
      • Figure 98. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Lanifibranor, 2020-2034
      • Figure 99. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 100. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Analysis, By Disease Stage, 2020, 2024 and 2034
      • Figure 101. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Disease Stage
      • Figure 102. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F1, 2020-2034
      • Figure 103. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F2, 2020-2034
      • Figure 104. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F3, 2020-2034
      • Figure 105. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F4, 2020-2034
      • Figure 106. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by NASH Stage F0, 2020-2034
      • Figure 107. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 108. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 109. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 110. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market (US$ Mn), by Retail & Specialty Pharmacies, 2020-2034
      • Figure 111. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 112. Middle East & Africa Non-alcoholic Steatohepatitis Treatment Market Attractiveness Analysis, By Country
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Non-alcoholic Steatohepatitis Treatment Market
  • 151363
  • June 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options